Heinrich Dreismann, Director at MYRIAD GENETICS INC (MYGN), sold 30,000 shares at $35.00 ($1.1M) on 2014-02-18, disclosed to the SEC on 2014-02-20.
Open-market sale of $1.1M MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MYGN | SELL | 2015-11-05 | $1.3M | — | Filing → |
| MYGN | SELL | 2013-05-10 | $935K | — | Filing → |